Summary
Hepatic and pancreatic damage owing to iron overload is often present in patients with beta-thalassemia major. In order to investigate B-cell function and hepatic insulin clearance in these patients, under a high transfusion program and regular chelation therapy, we studied the glucose (BG), insulin (IRI) and C-peptide (CPR) response and the CPR/IRI ratio after OGTT in 27 patients with Cooley’s anemia and in 10 sex- age- and weight-matched healthy subjects; we also studied BG and IRI levels after IVGTT in 9 beta-thalassemic patients and in 9 control subjects. Furthermore, BG, CPR, IRI and glucagon (IRG) response to arginine infusion were evaluated in 5 thalassemic patients with normal OGTT and in 5 age-, sex- and weight-matched normal children, in order to assess pancreatic A-cell function, too. OGTT and IVGTT were normal in the patients with beta-thalassemia major. Plasma IRI level 30 min after an oral glucose load and the insulinogenic index for cumulative intervals were significantly lower in thalassemics after OGTT, whereas the insulin response and insulinogenic index were normal following i.v. glucose. No significant difference was observed for the CPR/IRI ratio during OGTT between thalassemics and normal subjects. Finally, BG, CPR, IRI and IRG levels were similar in the thalassemic patients and in healthy children both fasting and following arginine infusion. Our data suggest that patients with beta-thalassemia major, under a high transfusion program and regular chelation therapy, may have normal glucose tolerance and normal hepatic insulin clearance in spite of iron overload in pancreas and liver. Insulin response to oral glucose was lower than the one to IVGTT, probably because of diminished secretion of the gastrointestinal hormones which stimulate insulin release.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barry M., Fynn D. M., Letski E. A., Risdon R. A.: Long term chelation therapy in thalassemia major: effect on liver iron concentration, liver histology and clinical progress — Brit. med. J.ii, 16, 1974.
Canale V. C., Steihnerz P., New M., Erlandson M.: Endocrine function in thalassemia major — Ann. N.Y. Acad. Sci.232, 333, 1974.
Chiumello G., Di Natale D., Longhi C., Rizzoli D., Terzoli S., Mauri R., Fontanelli G., Masera G.: High plasma insulin levels in thalassemia major: consequence of liver damage? In:Cao A., Carcassi U., Rowley P.T. (Eds): Int. Symposium on Recent Advances in Thalassemia. S. Margherita di Pula (Cagliari) 7/11 Giugno 1981. Alan R. Liss, Inc., New York, 1981; p. 108.
Costin G., Kogut M. D., Hyman C., Ortega J. A.: Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major — Diabetes26, 230, 1977.
Donowitz M., Hendler R., Spiro H. M., Binder H. J., Felig P.: Glucagon secretion in acute and chronic pancreatitis — Ann. intern. Med.83, 778, 1975.
Dymock I. W., Williams R.: Haemochromatosis and diabetes — Postgrad. med. J. (Suppl.), 79, 1971.
Foà P. P., Matsuyama T., Foà N. L.: Radioimmunoassay of glucagon. In:Abraham E. (Ed.): Hand-book of radioimmunoassay. Marcel Dekker Corp., New York, 1976; p. 299.
Grace N. D., Powell L. W.: Iron storage disorders of the liver — Gastroenterology64, 1257, 1974.
Heding L. G.: Radioimmunological determination of human C-peptide in serum — Diabetologia11, 541, 1975.
Huggett A. S. G., Nixon D. A.: Use of glucose-oxidase peroxidase and o-dianisine in the determination of blood and urine glucose — Lancetii, 368, 1957.
Johnston D. G., Alberti K. G. M. M., Wright R., Smith-Laing G., Stewart A. M., Sherlock S., Faber O., Binder C.: C-peptide and insulin liver disease — Diabetes27(Suppl. I), 201, 1978.
Karakash C., Assimacopoulos-Jeannet F., Jeanrenaud B.: An anomaly of insulin removal in perfused livers of obese-hyperglycemic (ob/ob) mice — J. clin. Invest.57, 117, 1976.
Lassman M. N., O’Brien R. T., Pearson H. A., Wise J. K., Donabedian R. K., Felig P., Genel M.: Endocrine evaluation in thalassemia major — Ann. N.Y. Acad. Sci.232, 226, 1974.
Lassman M. N., Genel M., Wise J. K., Hendler R., Felig P.: Carbohydrate homeostasis and pancreatic islet-cell function in thalassemia major — Ann. intern. Med.80, 65, 1974.
Maioli M., Brianda S., Farris A., Madeddu G., Pacifico A., Paolini T.: C-peptide e insulina nella cirrosi epatica - Studi Sassar.59, 1981.
McIntosh N.: Endocrinopathy in thalassemia major — Arch. Dis. Childh.51, 195, 1976.
Modell B.: Total management of thalassemia major — Arch. Dis. Childh.52, 489, 1977.
Muller W. W., Faloona G. R., Aguilar-Parada E., Unger R. H.: Abnormal alpha-cell function in diabetes: response to carbohydate and protein ingestion — New Engl. J. Med.283, 109, 1970.
Necheles T. F., Chung S., Sabdah R., Whitten D.: Intensive transfusion therapy in thalassemia major: An eight-year follow up — Ann. N.Y. Acad. Sci.232, 179, 1974.
Nosadini R., Del Prato S., Tiengo A., Duner E., Toffolo G., Cobelli C., Faronato P. P., Moghetti P., Muggeo M.: Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes — Diabetes31, 346, 1982.
Pozza G., Ghidoni A.: Studies on the diabetic syndrome of idiopathic haemochromatosis — Diabetologia4, 83, 1968.
Schafer A. I., Cheron G. R., Dluhy R., Cooper B., Gleason R. E., Soeldner J. S., Bunn H. F.: Clinical consequences of acquired transfusional iron overload in adults — New Engl. J. Med.304, 319, 1981.
Seltzner H. S., Allen E. W., Herron A. L. Jr., Brennan M. T.: Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus — J. clin. Invest.46, 323, 1967.
Tiengo A., Bessioud M., Valverde I., Tabbi Anneni A., Del Prato S., Alexandre J., Assan R.: Absence of islet alpha cell function in pancreatectomized patients — Diabetologia22, 25, 1982.
Toccafondi R., Maioli M., Meloni T.: Plasma insulin response to carbohydrate in Cooley’s anaemia — Riv. crit. Clin. Med.70, 6, 1970.
Unger R. H., Aguilar-Parada E., Muller W. A. Eisentraut A. M.: Studies of pancreatic alpha-cell function in normal and diabetic subjects — J. clin. Invest.49, 837, 1970.
Walsh C. H., Wright A. D., Williams J. W., Holder G.: A study of pituitary function in patients with idiopathic haemochromatosis — J. clin. Endocr.48, 901, 1979.
Wolman I. J., Ortolani M.: Some clinical features of Cooley’s anemia: patients as related to transfusion schedules — Ann. N.Y. Acad. Sci.165, 407, 1969.
Yalow R. S., Berson S. A.: Immunoassay of endogenous plasma insulin in man — J. clin. Invest.39, 1157, 1960.
Zuppinger K., Molinari B., Hirt A., Imbach P., Glugler E., Tonz O., Zurbrugg R. P.: Increased risk of diabetes mellitus in beta-thalassemia major due to iron overload — Helv. paediat. Acta34, 197, 1979.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maioli, M., Pacifico, A., Frulio, T. et al. Study of A- and B-cell function in beta-thalassemia major. Acta diabet. lat 20, 143–152 (1983). https://doi.org/10.1007/BF02624915
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02624915